RxDoctor Payments Data

Jennifer Robinson

Cardiovascular Disease · Iowa City, IANPI 1780672212

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,761 of the $36,542 with a category attached, or 92.4%. 5 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 45.6% of the total. Among cardiovascular disease clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,542in general payments, 2019–2025

Across 23 payments — averaging $1588.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$17K
  • Regeneron$12K
  • Pfizer$8K
  • Eli Lilly$91
  • Novartis$25
$1,242,244in research payments, 2019–2025

Across 234 payments — averaging $5308.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$554K
  • Novo Nordisk AS$292K
  • Eli Lilly$200K
  • Regeneron$54K
  • AstraZeneca$53K
  • Novartis$26K
  • plus $64K from 5 others

What the payments were for

  • Consulting fees$33,76192%
  • Travel & lodging$2,3366%
  • Food & beverage$4241%
  • Education$210%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi-aventis U.S. LLC7$16,670
Regeneron11$11,853
Pfizer3$7,903
Eli Lilly1$91
Novartis1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,542 in reported general payments places this provider in the 95th percentile of 142 cardiovascular disease providers in Iowa.

See all cardiovascular disease providers in Iowa →

Other cardiovascular disease in Iowa City

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →